Aromatase inhibitors and mental function [2]

Journal of the American Geriatrics Society

Volumn 53, Issue 1, 2005, Pages 166-

  Tralongo, Paolo ^a   Dimari, Anna ^a   Repetto, Lazzaro ^b  

^a G Di Maria Hospital   (Italy)

^b INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN; EXEMESTANE; LETROZOLE; TAMOXIFEN;

AROMATIZATION; BREAST CANCER; COGNITIVE DEFECT; DEMENTIA; DRUG INHIBITION; DRUG MECHANISM; ENZYME INHIBITION; ESTROGEN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LEARNING; LETTER; MEMORY; MEMORY DISORDER; POSTMENOPAUSE; VERBAL MEMORY; AGED; BREAST TUMOR; FEMALE; NOTE;

AGED; AROMATASE INHIBITORS; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; POSTMENOPAUSE;

EID: 20044384690     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53031_2.x     Document Type: Letter

References (8)

1. Arora A, Potter JF. Aromatase inhibitors: Current indications and future prospects for treatment of postmenopausal breast cancer. J Am Geriatr Soc 2004;52:611-616.
2. Coombes RC, Hall E, Gibson LJ et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081-1092.
3. Baum M, Budzar AU, Cuzick J et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer; first results of the ATAC randomized trial. Lancet 2002;360:1520-1528.
4. Goss PE, Ingle JN, Martino S et al. A randomized trial of letrozole in post-menopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349:1793-1802.
5. Sherwin BB. Estrogen and cognitive functioning in women. Endocr Rev 2003;24:133-151.
6. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 1997;388:507-525.
7. Jenkins VA, Fallowfield LJ, Schilling V et al. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? Breast Cancer Res Treat 2002;76:548.
8. McEwen BS. Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocrinol Metab 1999;84:1790-1797.